Comparing Basilic and Cephalic Vein Approaches for Midline Catheter Placement in Children
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Midline catheter placement via basilic vein, Midline catheter placement via cephalic vein.
- Who it may be relevant to
- Registry conditions: Vascular Access Device Complications. Basic parameters: 2 years — 17 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- South Korea
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Comparing Basilic and Cephalic Vein Approaches for Midline Catheter Placement in Children: A Randomized Controlled Trial
Overview
This prospective randomized controlled trial aims to compare basilic vein and cephalic vein approaches for midline catheter placement in pediatric patients undergoing general anesthesia. Participants aged 2 to 17 years who require midline catheter insertion will be randomly assigned 1:1 to either the basilic vein group or the cephalic vein group. The primary outcome is the clinical blood sampling success rate during the catheter dwell period, defined as successful aspiration of ≥2 mL of blood through the midline catheter at least once without additional venipuncture. Secondary outcomes include operator-rated difficulty, number of puncture attempts, first attempt cannulation success rate, vein diameter and depth, catheter dwell time, catheter-related complications, and patient satisfaction. A total of 96 participants (48 per arm) will be enrolled at Seoul National University Children's Hospital.
Interventions
- Procedure Midline catheter placement via basilic vein
Midline catheter placement via basilic vein under ultrasound guidance - Procedure Midline catheter placement via cephalic vein
Midline catheter placement via cephalic vein under ultrasound guidance
Primary outcome measures
- Clinical blood sampling success rate during catheter dwell period [Time frame: From catheter insertion until catheter removal (up to 7 days postoperatively)]
Secondary outcome measures (8)
- Operator-rated difficulty score [Time frame: At time of catheter insertion]
- Number of puncture attempts [Time frame: At time of catheter insertion]
- First attempt cannulation success rate [Time frame: At time of catheter insertion]
- Standardized blood aspiration success [Time frame: Intraoperatively and postoperative day 1]
- Allocated vein diameter and depth [Time frame: At time of catheter insertion]
- Catheter dwell time [Time frame: From catheter insertion until catheter removal (up to 7 days postoperatively)]
- Catheter-related complications [Time frame: From catheter insertion until catheter removal (up to 7 days postoperatively)]
- Patient satisfaction score [Time frame: At catheter removal (up to 7 days postoperatively)]
Eligibility criteria
Inclusion criteria
- Age 2-17 years undergoing general anesthesia
- Midline catheter placement deemed necessary by attending anesthesiologist (≥1 of: expected ≥2 postop blood draws; expected blood loss ≥40% EBV; continuous antibiotic therapy; hospitalization ≥7 days; surgical team request)
Exclusion criteria
- Need for central venous catheter per surgical team
- Coagulopathy
- History of severe thrombosis
- Other investigator-determined ineligibility
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: Yes
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Prevention
Study locations
South Korea · 1 center
- Hee-Soo Kim — Seoul
Identifiers
NCT: NCT07509359 · 2602-130-1721